Rubert A, Bagán L, Bagán JV. Retraction: Oral leukoplakia, a clinical-histopathological study in 412 patients. J Clin Exp Dent. 2021;13(5):e426-32.

 

doi:10.4317/jced.532746

https://doi.org/10.4317/jced.532746

___________

 

References

1. van der Waal I. Oral potentially malignant disorders: is malignant transformation predictable and preventable?. Med Oral Patol Oral Cir Bucal. 2014;19:e386-90.
https://doi.org/10.4317/medoral.20205
PMid:24905952 PMCid:PMC4119315

 

2. Brouns ER, Baart JA, Bloemena E, Karagozoglu H, van der Waal I. The relevance of uniform reporting in oral leukoplakia: definition, certainty factor and staging based on experience with 275 patients. Med Oral Patol Oral Cir Bucal. 2013;18:e19-26.
https://doi.org/10.4317/medoral.18756
PMid:23085711 PMCid:PMC3548640

 

3. van der Waal I. Oral leukoplakia, the ongoing discussion on definition and terminology. Med Oral Patol Oral Cir Bucal. 2015;20:e685-92.
https://doi.org/10.4317/medoral.21007
PMid:26449439 PMCid:PMC4670248

 

4. Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39:770-80.
https://doi.org/10.1016/S1368-8375(03)00102-7

 

5. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008;37:1-10.
https://doi.org/10.1111/j.1600-0714.2007.00579.x
PMid:18154571

 

6. García-Pola Vallejo MJ, García Martín JM. Oral leukoplakia. Aten Primaria. 2002;29:39-49.

 

7. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol. 2010;46:423-5.
https://doi.org/10.1016/j.oraloncology.2010.02.016
PMid:20308005

 

8. Kumar A, Cascarini L, McCaul JA, Kerawala CJ, Coombes D, Godden D, Brennan PA. How should we manage oral leukoplakia? Br J Oral Maxillofac Surg. 2013;51:377-83.
https://doi.org/10.1016/j.bjoms.2012.10.018
PMid:23159193

 

9. Lodi G, Porter S. Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med. 2008;37:63-9.
https://doi.org/10.1111/j.1600-0714.2007.00575.x
PMid:18197849

 

10. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45:317-23.
https://doi.org/10.1016/j.oraloncology.2008.05.016
PMid:18674954

 

11. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575-80.
https://doi.org/10.1111/j.1600-0714.2007.00582.x
PMid:17944749

 

12. Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer.1984;53:563-8.
https://doi.org/10.1002/1097-0142(19840201)53:3<563::AID-CNCR2820530332>3.0.CO;2-F

 

13. Schepman KP, Bezemer PD, van der Meij EH, Smeele LE, van der Waal I. Tobacco usage in relation to the anatomical site of oral leukoplakia. Oral Dis. 2001;7:25-7.
https://doi.org/10.1034/j.1601-0825.2001.70105.x
PMid:11354917

 

14. Napier SS, Cowan CG, Gregg TA, Stevenson M, Lamey PJ, Toner PG. Potentially malignant oral lesions in Northern Ireland: size (extent) matters. Oral Dis. 2003;9:129-37.
https://doi.org/10.1034/j.1601-0825.2003.02888.x
PMid:12945594

 

15. Maserejian NN, Giovannucci E, Rosner B, Zavras A, Joshipura K. Prospective study of fruits and vegetables and risk of oral premalignant lesions in men. Am J Epidemiol. 2006;164:556-66.
https://doi.org/10.1093/aje/kwj233
PMid:16847039

 

16. Vladimirov BS, Schiodt M. The effect of quitting smoking on the risk of unfavorable events after surgical treatment of oral potentially malignant lesions. Int J Oral Maxillofac Surg. 2009;38:1188-93.
https://doi.org/10.1016/j.ijom.2009.06.026
PMid:19640683

 

17. Haya-Fernández MC, Bagán JV, Murillo-Cortés J, Poveda-Roda R, Calabuig C. The prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma. Oral Dis. 2004;10:346-8.
https://doi.org/10.1111/j.1601-0825.2004.01031.x
PMid:15533209

 

18. Scheifele C, Reichart PA, Dietrich T. Low prevalence of oral leukoplakia in a representative sample of the US population. Oral Oncol. 2003;39:619-25.
https://doi.org/10.1016/S1368-8375(03)00050-2

 

19. Vázquez-Álvarez R, Fernández-González F, Gándara-Vila P, Reboiras- López D, García-García A, Gándara-Rey JM. Correlation between clini- cal and pathologic diagnosis in oral leukoplakia in 54 patients. Med Oral Patol Oral Cir Bucal. 2010;15:e832-8.
https://doi.org/10.4317/medoral.15.e832

 

20. Starzyńska A, Pawłowska A, Renkielska D, Michajłowski I, Sobjanek M, Błażewicz I. Oral premalignant lesions: epidemiological and clinical analysis in the northern Polish population. Postȩpy Dermatol Alergol. 2014;31:341-350.
https://doi.org/10.5114/pdia.2014.40932
PMid:25610347 PMCid:PMC4293380

 

21. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42:461-74.
https://doi.org/10.1016/j.oraloncology.2005.08.011
PMid:16316774

 

22. Brouns E, Baart J, Karagozoglu Kh, Aartman I, Bloemena E, van der Waal I. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. Oral Dis. 2014;20:e19-24.
https://doi.org/10.1111/odi.12095
PMid:23521625

 

23. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002;52:195-215.
https://doi.org/10.3322/canjclin.52.4.195
PMid:12139232

 

24. Gandara-Vila P, Perez-Sayans M, Suarez-Penaranda JM, Gallas-Torreira M, Somoza-Martin J, Reboiras-Lopez MD, et al. Survival study of leukoplakia malignant transformation in a region of northern Spain. Med Oral Patol Oral Cir Bucal. 2018;23:e413-e420.
https://doi.org/10.4317/medoral.22326
PMid:29924757 PMCid:PMC6051679

 

25. Einhorn J, Wersall J. Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa. Cancer. 1967;20:2189-93.
https://doi.org/10.1002/1097-0142(196712)20:12<2189::AID-CNCR2820201218>3.0.CO;2-M

 

26. Pindborg JJ, Renstrup G, Jolst O, Roed-Peterson B. Studies in oral leukoplakia: A preliminary report on the period prevalence of malignant transformation in leukoplakia based in a follow-up study of 248 patients. J Am Dent Assoc 1968;76:767-71.
https://doi.org/10.14219/jada.archive.1968.0127
PMid:5238856

 

27. Roed-Petersen B. Cancer development in oral leukoplakia follow-up of 331 patients. J Dent Res. 1971;50:711-2.

 

28. Banoczy J. Follow-up studies in oral leukoplakia. J Max Fac Surg. 1977;5:69-75.
https://doi.org/10.1016/S0301-0503(77)80079-9

 

29. Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M, Odell E, et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med. 2011;40:677-83
https://doi.org/10.1111/j.1600-0714.2011.01054.x
PMid:21762430

 

30. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003;14:47-62.
https://doi.org/10.1177/154411130301400105
PMid:12764019